Format

Send to

Choose Destination
Microbiome. 2015 May 5;3:19. doi: 10.1186/s40168-015-0083-8. eCollection 2015.

Deriving accurate microbiota profiles from human samples with low bacterial content through post-sequencing processing of Illumina MiSeq data.

Author information

1
Menzies School of Health Research, Child Health Division, Charles Darwin University, Darwin, NT Australia ; School of Medicine, Flinders University, Bedford Park, Adelaide, SA Australia ; Infection and Immunity Theme, South Australia Health and Medical Research Institute, North Terrace, Adelaide, SA Australia.
2
Infection and Immunity Theme, South Australia Health and Medical Research Institute, North Terrace, Adelaide, SA Australia.
3
School of Medicine, Flinders University, Bedford Park, Adelaide, SA Australia.
4
Infection and Immunity Theme, South Australia Health and Medical Research Institute, North Terrace, Adelaide, SA Australia ; School of Biological Sciences, Flinders University, Adelaide, South Australia 5001 Australia.
5
Menzies School of Health Research, Child Health Division, Charles Darwin University, Darwin, NT Australia.
6
Department of Otolaryngology, University of Melbourne, Melbourne, VIC Australia.
7
School of Medicine, Flinders University, Bedford Park, Adelaide, SA Australia ; Infection and Immunity Theme, South Australia Health and Medical Research Institute, North Terrace, Adelaide, SA Australia.

Abstract

BACKGROUND:

The rapid expansion of 16S rRNA gene sequencing in challenging clinical contexts has resulted in a growing body of literature of variable quality. To a large extent, this is due to a failure to address spurious signal that is characteristic of samples with low levels of bacteria and high levels of non-bacterial DNA. We have developed a workflow based on the paired-end read Illumina MiSeq-based approach, which enables significant improvement in data quality, post-sequencing. We demonstrate the efficacy of this methodology through its application to paediatric upper-respiratory samples from several anatomical sites.

RESULTS:

A workflow for processing sequence data was developed based on commonly available tools. Data generated from different sample types showed a marked variation in levels of non-bacterial signal and 'contaminant' bacterial reads. Significant differences in the ability of reference databases to accurately assign identity to operational taxonomic units (OTU) were observed. Three OTU-picking strategies were trialled as follows: de novo, open-reference and closed-reference, with open-reference performing substantially better. Relative abundance of OTUs identified as potential reagent contamination showed a strong inverse correlation with amplicon concentration allowing their objective removal. The removal of the spurious signal showed the greatest improvement in sample types typically containing low levels of bacteria and high levels of human DNA. A substantial impact of pre-filtering data and spurious signal removal was demonstrated by principal coordinate and co-occurrence analysis. For example, analysis of taxon co-occurrence in adenoid swab and middle ear fluid samples indicated that failure to remove the spurious signal resulted in the inclusion of six out of eleven bacterial genera that accounted for 80% of similarity between the sample types.

CONCLUSIONS:

The application of the presented workflow to a set of challenging clinical samples demonstrates its utility in removing the spurious signal from the dataset, allowing clinical insight to be derived from what would otherwise be highly misleading output. While other approaches could potentially achieve similar improvements, the methodology employed here represents an accessible means to exclude the signal from contamination and other artefacts.

KEYWORDS:

16S rRNA; Contamination; MiSeq; Otitis media; Pair-end reads; QIIME; Respiratory

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center